Compile Data Set for Download or QSAR
Report error Found 80 Enz. Inhib. hit(s) with all data for entry = 3252
TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395359(US10308636, Example 44-6)
Affinity DataIC50: 0.780nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395327(US10308636, Example 4-15)
Affinity DataIC50: 0.940nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395381(US10308636, Example 74)
Affinity DataIC50: 1.10nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395380(US10308636, Example 75)
Affinity DataIC50: 1.10nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395378(US10308636, Example 110)
Affinity DataIC50: 1.10nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395364(US10308636, Example 46-5)
Affinity DataIC50: 1.20nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395361(US10308636, Example 45-1)
Affinity DataIC50: 1.5nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395345(US10308636, Example 32-2)
Affinity DataIC50: 1.70nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395325(US10308636, Example 4-1)
Affinity DataIC50: 1.70nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395383(US10308636, Example 78)
Affinity DataIC50: 1.70nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395386(US10308636, Example 83)
Affinity DataIC50: 1.80nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395326(US10308636, Example 4-3)
Affinity DataIC50: 2.10nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395313(US10308636, Example 1-34)
Affinity DataIC50: 2.10nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395379(US10308636, Example 72)
Affinity DataIC50: 2.20nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395320(US10308636, Example 2-7)
Affinity DataIC50: 2.5nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395324(US10308636, Example 3-7)
Affinity DataIC50: 2.5nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395372(US10308636, Example 59)
Affinity DataIC50: 2.60nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395347(US10308636, Example 35-1)
Affinity DataIC50: 2.70nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395321(US10308636, Example 2-8)
Affinity DataIC50: 2.90nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395337(US10308636, Example 17)
Affinity DataIC50: 2.90nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395328(US10308636, Example 5-2)
Affinity DataIC50: 3.20nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395336(US10308636, Example 14)
Affinity DataIC50: 3.20nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395388(US10308636, Example 23-1)
Affinity DataIC50: 3.30nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395384(US10308636, Example 80)
Affinity DataIC50: 3.30nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395318(US10308636, Example 1-63)
Affinity DataIC50: 3.30nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395322(US10308636, Example 2-11)
Affinity DataIC50: 3.70nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395375(US10308636, Example 67)
Affinity DataIC50: 3.90nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395316(US10308636, Example 1-44)
Affinity DataIC50: 4.20nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395348(US10308636, Example 37-3)
Affinity DataIC50: 4.30nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395363(US10308636, Example 46-4)
Affinity DataIC50: 4.40nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395385(US10308636, Example 82)
Affinity DataIC50: 4.60nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395335(US10308636, Example 12)
Affinity DataIC50: 4.70nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395376(US10308636, Example 108)
Affinity DataIC50: 5nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395374(US10308636, Example 61)
Affinity DataIC50: 5.20nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395323(US10308636, Example 2-16)
Affinity DataIC50: 5.70nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395331(US10308636, Example 8)
Affinity DataIC50: 6.10nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395333(US10308636, Example 10)
Affinity DataIC50: 6.40nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395387(US10308636, Example 104)
Affinity DataIC50: 6.80nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395344(US10308636, Example 31-2)
Affinity DataIC50: 6.80nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395309(US10308636, Example 1-3)
Affinity DataIC50: 6.90nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395338(US10308636, Example 21-2)
Affinity DataIC50: 6.90nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395332(US10308636, Example 9)
Affinity DataIC50: 7.90nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395308(US10308636, Example 1-1)
Affinity DataIC50: 8nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395370(US10308636, Example 55)
Affinity DataIC50: 8.10nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395366(US10308636, Example 48)
Affinity DataIC50: 8.20nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395355(US10308636, Example 43-1)
Affinity DataIC50: 8.5nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395346(US10308636, Example 34)
Affinity DataIC50: 8.80nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395365(US10308636, Example 47-1)
Affinity DataIC50: 9nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395362(US10308636, Example 46-1)
Affinity DataIC50: 9nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM395329(US10308636, Example 6)
Affinity DataIC50: 9.10nMAssay Description:As a buffer used for the enzymatic reaction of DGAT1, 100 mM Tris-HCl (pH7.4), 200 mM Sucrose, and 20 mM MgCl2, 0.125% Bovin Serum Albumin (BSA) were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

Displayed 1 to 50 (of 80 total ) | Next | Last >>
Jump to: